Form 8-K SIMULATIONS PLUS INC For: Jul 24
http://archive.fast-edgar.com/20140725/ATZZGG2CI2228ZZ2222J2ZZZSQQNZ26RM462
Filed on: July 25, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA
- California Nanotechnologies Announces Q2 2027 Results
- Neeyamo Recognized as a Leader and Star Performer in Everest Group's 2026 Multi-Country Payroll PEAK Matrix® Assessment
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share